Next-Generation Sequencing (NGS) Market by Platforms, Services, & Application –Global Forecasts


Posted April 10, 2017 by Fiona-QYR

The global NGS market is expected to reach USD 10,371.1 million by 2021 from USD 4,031.7 million in 2016, at a CAGR of 20.8% between 2016 and 2021. North America is expected to hold the largest share of the global NGS market in 2016.

 
Market Research Report Store(MRRS) adds "Next-Generation Sequencing (NGS) Market by Platforms (HiSeq, MiSeq, HiSeq X Ten/X Five, Nextseq500, Ion Proton, PGM, IonS5, PacBio & Sequel), Services (Targeted Sequencing, De novo), & Application (Diagnostic, Drug Discovery) – Global Forecasts to 2021" latest studies, published in March 2017. It is a professional and in-depth study.

Scope of the Report:

The global NGS market is expected to reach USD 10,371.1 million by 2021 from USD 4,031.7 million in 2016, at a CAGR of 20.8% between 2016 and 2021. North America is expected to hold the largest share of the global NGS market in 2016. The NGS market is broadly segmented into products & services, technology, application, and end user. By products & services, the NGS market is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics. The consumables segment is expected to command the major share of the NGS market, by products& services, in 2016.

Geographically, the report covers four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the global NGS market in 2016, followed by Europe. Asia-Pacific NGS market is poised to witness highest growth rate during the forecast period from 2016 to 2021 due to a number of factors including improving healthcare infrastructure and favorable government initiatives.

Market growth is majorly driven by the technological advancements in NGS products, increasing applications of NGS, entry of new market players, increasing partnerships & collaborations among market players, and growing incidences of cancer, inherited rare disorders, and pre- and neo-natal disorders.

As of 2015, the global NGS market was dominated by Illumina, Inc. (U.S.); Thermo Fisher Scientific, Inc. (U.S.); and Pacific Biosciences of California, Inc. (U.S.) which together held a share of 94% of the overall NGS platforms market. New product launches & product enhancements; agreements, collaborations, & partnerships, geographic expansions; strategic acquisitions; and others (offering research fund & grants and organizing conferences/seminars) are the major strategies adopted by most market players to achieve growth in the global NGS market.

Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis —market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the NGS market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on NGS products offered by the top 10 players in the NGS market. The report analyzes the NGS market by products & services, technology, application, and end user

• Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, product enhancements, and new product launches in the NGS market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various NGS devices across four geographies

• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the NGS market

Some parts from Contents

6.3 NGS PLATFORMS, CONSUMABLES, & SERVICES FOR PLATFORMS 61
6.3.1 NGS PLATFORMS MARKET 62
6.3.1.1 Illumina 63
6.3.1.1.1 HiSeq Series 64
6.3.1.1.2 HiSeq X Ten & HiSeq X Five 64
6.3.1.1.3 MiSeq Series 65
6.3.1.1.4 NextSeq500 66
6.3.1.2 Thermo Fisher Scientific (Life Technologies) 67
6.3.1.2.1 SOLiD Series 68
6.3.1.2.2 Ion Torrent Platforms 69
6.3.1.2.2.1 Ion PGM 69
6.3.1.2.2.2 Ion Proton 69
6.3.1.2.2.3 Ion S5 & S5 XL 70
6.3.1.3 Pacific Biosciences 71
6.3.1.3.1 PacBio RS II 72
6.3.1.3.2 Sequel System 72
6.3.1.4 Recently Launched Sequencing Platforms 73
...

Get full report details at:
https://www.marketresearchreportstore.com/shop/next-generation-sequencing-ngs-market-by-platforms-hiseq-miseq-hiseq-x-tenx-five-nextseq500-ion-proton-pgm-ions5-pacbio-sequel-services-targeted-sequencing-de-novo-application-di

Contact :
Fiona
Sales Director
Tel: +00-1-626-3463946 - U.S
E-mail: [email protected]
Web:http://www.marketresearchreportstore.com/

About Market Research Report Store
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Report Store
Country China
Categories Business
Last Updated April 10, 2017